A gram-scale
synthesis of iboxamycin, an antibiotic candidate bearing a fused bicyclic amino
acid residue, is presented. A pivotal transformation in the route involves an
intramolecular hydrosilylation–oxidation sequence to set the ring-fusion
stereocenters of the bicyclic scaffold. Other notable features of the synthesis
include a high-yielding, highly diastereoselective alkylation of a
pseudoephenamine amide, a convergent sp<sup>3</sup>–sp<sup>2</sup> Negishi
coupling, and a one-pot transacetalization–reduction reaction to form the
target compound’s oxepane ring. Implementation of this synthetic strategy has
provided ample quantities of iboxamycin to allow for its <i>in vivo</i> profiling in murine models of infection.